glp-1 medications onset time Timeline of discovery and clinical development. (a) Key events in GLP-1 Medications for Weight Loss:

doi: 10.1210/jc.2003-031403 [DOI] [PubMed] [Google Scholar] 208

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: results from the Breast Cancer Weight Loss (BWEL) trial

Build trust as collaborators within a client's broader health team

Nat Rev (2014) 10(8):48898.10.1038/nrendo.2014.60 157 StaelsBFonsecaVA

GLP-1 receptor agonist medications mimic these effects pharmacologically, producing several mechanisms that contribute to weight loss: Reduced appetite and food intake by activating satiety signaling in the brain, these medications meaningfully reduce hunger and food preoccupation for most patients Slower gastric emptying food remains in the stomach longer, prolonging the feeling of fullness after meals Improved insulin sensitivity better glucose regulation reduces post-meal energy crashes that often drive cravings Lower preference for high-calorie foods many patients report shifts in food preferences toward lighter, less calorie-dense options Tirzepatide adds a second mechanism by also activating GIP (glucose-dependent insulinotropic polypeptide) receptors, which is believed to contribute to its greater weight loss effect compared to semaglutide alone

Anticonvulsants Drugs that treat seizures can affect the metabolism of hormonal pills, reducing the efficacy of oral contraceptives